BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36115104)

  • 1. Methylation patterns of Lys9 and Lys27 on histone H3 correlate with patient outcome and tumor progression in lung cancer.
    Zhang Y; Zheng B; Lou K; Xu X; Xu Y
    Ann Diagn Pathol; 2022 Dec; 61():152045. PubMed ID: 36115104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation Patterns of Lys9 and Lys27 on Histone H3 Correlate with Patient Outcome in Gastric Cancer.
    Li Y; Guo D; Sun R; Chen P; Qian Q; Fan H
    Dig Dis Sci; 2019 Feb; 64(2):439-446. PubMed ID: 30350241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High methylation levels of histone H3 lysine 9 associated with activation of hypoxia-inducible factor 1α (HIF-1α) predict patients' worse prognosis in human hepatocellular carcinomas.
    Qian Y; Li Y; Zheng C; Lu T; Sun R; Mao Y; Yu S; Fan H; Zhang Z
    Cancer Genet; 2020 Jul; 245():17-26. PubMed ID: 32534446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High expression of trimethylated histone H3 at lysine 27 predicts better prognosis in non-small cell lung cancer.
    Chen X; Song N; Matsumoto K; Nanashima A; Nagayasu T; Hayashi T; Ying M; Endo D; Wu Z; Koji T
    Int J Oncol; 2013 Nov; 43(5):1467-80. PubMed ID: 23969945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H3K9me3, H3K36me3, and H4K20me3 Expression Correlates with Patient Outcome in Esophageal Squamous Cell Carcinoma as Epigenetic Markers.
    Zhou M; Li Y; Lin S; Chen Y; Qian Y; Zhao Z; Fan H
    Dig Dis Sci; 2019 Aug; 64(8):2147-2157. PubMed ID: 30788686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H3K4 Methylation Status and Lysine Specific Methyltransferase KMT2C Expression Correlate with Prognosis in Lung Adenocarcinoma.
    Bosgana P; Nikou S; Dimitrakopoulos FI; Logotheti S; Tzelepi V; Kalophonos C; Bravou V; Kourea E; Sampsonas F; Zolota V
    Curr Mol Pharmacol; 2021; 14(6):1028-1036. PubMed ID: 32867667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks.
    Yuan C; Chen H; Tu S; Huang HY; Pan Y; Gui X; Kuang M; Shen X; Zheng Q; Zhang Y; Cheng C; Hong H; Tao X; Peng Y; Yao X; Meng F; Ji H; Shao Z; Sun Y
    Genome Biol; 2021 May; 22(1):156. PubMed ID: 34001209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of histone marks H3K27me3 and H3K9me3 and modifying enzymes EZH2, SETDB1 and LSD-1 in colorectal cancer.
    Carvalho S; Freitas M; Antunes L; Monteiro-Reis S; Vieira-Coimbra M; Tavares A; Paulino S; Videira JF; Jerónimo C; Henrique R
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2127-2137. PubMed ID: 30105513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypo-trimethylation of Histone H3 Lysine 4 and Hyper-tri/dimethylation of Histone H3 Lysine 27 as Epigenetic Markers of Poor Prognosis in Patients with Primary Central Nervous System Lymphoma.
    Kim HG; Kim MS; Lee YS; Lee EH; Kim DC; Lee SH; Kim YZ
    Cancer Res Treat; 2022 Jul; 54(3):690-708. PubMed ID: 34793663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global histone H3 lysine 27 triple methylation levels are reduced in vessels with advanced atherosclerotic plaques.
    Wierda RJ; Rietveld IM; van Eggermond MC; Belien JA; van Zwet EW; Lindeman JH; van den Elsen PJ
    Life Sci; 2015 May; 129():3-9. PubMed ID: 25445221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global histone modification of histone H3 in colorectal cancer and its precursor lesions.
    Nakazawa T; Kondo T; Ma D; Niu D; Mochizuki K; Kawasaki T; Yamane T; Iino H; Fujii H; Katoh R
    Hum Pathol; 2012 Jun; 43(6):834-42. PubMed ID: 21917293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential
    Lin S; Tian C; Li J; Liu B; Ma T; Chen K; Gong W; Wang JM; Huang J
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor-1α cooperates with histone Lys methylation to predict prognosis in esophageal squamous cell carcinoma.
    Shen X; Li Y; Xu Y; Liu M; Zhang Q; Yin R; Zhou M; Lin S; Fan H
    Biomark Med; 2021 May; 15(7):509-522. PubMed ID: 33856264
    [No Abstract]   [Full Text] [Related]  

  • 14. Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.
    Zhang QH; Dai XH; Dai ZM; Cai YN
    Genet Mol Res; 2015 Aug; 14(3):9200-14. PubMed ID: 26345853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Validation of 7-lncRNA Signature of Epigenetic Disorders by Comprehensive Epigenetic Analysis.
    Cao P; Li F; Xiao Y; Hu S; Kong K; Han P; Yue J; Deng Y; Zhao Z; Wu D; Zhang L; Zhao B
    Dis Markers; 2022; 2022():5118444. PubMed ID: 35237359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H3K27me3 protein is a promising predictive biomarker of patients' survival and chemoradioresistance in human nasopharyngeal carcinoma.
    Cai MY; Tong ZT; Zhu W; Wen ZZ; Rao HL; Kong LL; Guan XY; Kung HF; Zeng YX; Xie D
    Mol Med; 2011; 17(11-12):1137-45. PubMed ID: 21738951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone modification patterns correlate with patient outcome in oral squamous cell carcinoma.
    Chen YW; Kao SY; Wang HJ; Yang MH
    Cancer; 2013 Dec; 119(24):4259-67. PubMed ID: 24301303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of aberrant trimethylation of histone H3 lysine 27 by inflammation in mouse colonic epithelial cells.
    Takeshima H; Ikegami D; Wakabayashi M; Niwa T; Kim YJ; Ushijima T
    Carcinogenesis; 2012 Dec; 33(12):2384-90. PubMed ID: 22976929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct regulation of histone H3 methylation at lysines 27 and 9 by CpG methylation in Arabidopsis.
    Mathieu O; Probst AV; Paszkowski J
    EMBO J; 2005 Aug; 24(15):2783-91. PubMed ID: 16001083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic modifications promote the expression of the orphan nuclear receptor NR0B1 in human lung adenocarcinoma cells.
    Lu Y; Liu Y; Liao S; Tu W; Shen Y; Yan Y; Tao D; Lu Y; Ma Y; Yang Y; Zhang S
    Oncotarget; 2016 Jul; 7(28):43162-43176. PubMed ID: 27281610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.